Login to Your Account



JPMorgan Healthcare Conference

More Good Phase III Results With Celgene's Thalidomide

By Randall Osborne


Tuesday, January 10, 2006
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription